Accelr8 Technology Corporation Announces Reduced Losses, and Presentation of Results for Rapid MRSA Identification at ASM’s 107th General Meeting

DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (Amex: AXK) reported a loss of $476,537 or $0.05 per share on net revenues of $22,687 for the quarter ended April 30, 2007. In the comparable three-month period of fiscal 2006, Accelr8 reported a net loss of $788,855 or $0.08 per share on net revenues of $19,800.

MORE ON THIS TOPIC